Includes intraocular lenses (IOLs) for cataract surgery, refractive lasers (LASIK, SMILE), glaucoma implants (MIGS), retinal therapies (intravitreal delivery), and diagnostic OCT. Products include intraocular lenses, glaucoma implants, lasers, diagnostic imaging and contact lenses. Many surgical products are Class II or III, with PMA required for implants like IOLs. Ambulatory surgery centers are a key site of care and buyer.

Why it matters

Alcon, J&J Vision, Bausch+Lomb, and Carl Zeiss Meditec are anchors. Premium IOLs (presbyopia-correcting) and MIGS are key growth drivers; reimbursement varies sharply between premium-channel cash pay and standard Medicare.

Common pitfalls

•Ophthalmology devices with novel technologies or higher risks, like some implantable devices, often require extensive clinical data before market approval, a common pitfall for manufacturers.
•Misinterpreting device classification rules can lead to incorrect regulatory pathways, causing significant delays in market access.
•Failing to adequately address cybersecurity risks for connected ophthalmology devices can result in non-compliance with regulations such as those outlined in FDA premarket submissions for cybersecurity.
•Not aligning with international standards for quality management systems, such as ISO 13485, can create compliance challenges across different markets.

Sources

AAO · AAO
MedTech Europe - Facts & Figures · MedTech Europe
MedTech Dive · MedTech Dive
Ophthalmology Program: Research on Ophthalmology Medical Devices · FDA

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.